Aurinia Pharmaceuticals: And Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (“the Exchange Act”), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended. In Addition, The Information Included In This Current Report On Form 8k And The Exhibit Hereto, That Is Furnished Pursuant To This Item 2.02 Shall Not Be Incorporated By Reference In Any Of Aurinia's Filings Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing, Except As Expressly Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Aurinia Pharmaceuticals Inc
• Paese di registrazione
  Canada
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***